Drug‐induced methaemoglobinaemia following elective coronary artery bypass grafting
Authors:
- 12 June 2007
- journal article
- case report
- Published by Wiley in Anaesthesia
- Vol. 62 (7) , 737-740
Abstract
Summary: Dapsone can alter the oxygen carrying capacity of haemoglobin. Some patients are more susceptible to these effects because of genetic factors, comorbidities or peri‐operative factors such as anaemia. We present a 57‐year‐old lady who underwent elective coronary artery bypass grafting. Deterioration in neurological and respiratory condition prompted a review of her drug treatment. A combination of long‐term dapsone therapy, co‐existing cardiac and respiratory disease, postoperative anaemia and renal impairment contributed to her decompensation, despite a relatively low level of methaemoglobin. Successful management included stopping dapsone therapy, supportive care and administration of ascorbic acid.Keywords
This publication has 12 references indexed in Scilit:
- Anesthetic Management of a Patient with MethemoglobinemiaSouthern Medical Journal, 2003
- Occupational MethaemoglobinaemiaToxicological Reviews, 2003
- A Review of Risk Factors for Adverse Neurologic Outcome After Cardiac SurgeryThe Journal of ExtraCorporeal Technology, 2002
- Neurological and cognitive disorders after coronary artery bypass graftingCurrent Opinion in Cardiology, 2001
- Drug-Induced Methaemoglobinaemia Treatment IssuesDrug Safety, 1996
- Determinants of cerebral perfusion during cardiopulmonary bypassJournal of Cardiothoracic and Vascular Anesthesia, 1996
- Neuropsychologic change after cardiac surgery: A critical reviewJournal of Cardiothoracic and Vascular Anesthesia, 1996
- Dapsone — induced methemoglobinemia: an anesthetic riskInternational Journal of Pediatric Otorhinolaryngology, 1995
- Chronic methemoglobinemia: Improving hemoglobin saturation monitoring during anesthesiaJournal of Clinical Monitoring and Computing, 1994
- Drug- and Chemical-Induced MethaemoglobinaemiaMedical Toxicology, 1986